Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 290 target price by research analysts at Jefferies Group LLC in a research report issued on Thursday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Jefferies Group LLC’s target price suggests a potential upside of 26.75% from the stock’s current price.
Several other research firms also recently commented on ROG. Deutsche Bank AG set a CHF 255 price objective on shares of Roche Holding and gave the stock a “neutral” rating in a research note on Monday, September 11th. J P Morgan Chase & Co reiterated a “buy” rating on shares of Roche Holding in a research note on Monday, September 11th. Goldman Sachs Group, Inc. (The) set a CHF 325 price objective on shares of Roche Holding and gave the stock a “buy” rating in a research note on Monday, September 11th. UBS AG restated a “neutral” rating on shares of Roche Holding in a research report on Tuesday, September 5th. Finally, Berenberg Bank set a CHF 273 target price on shares of Roche Holding and gave the company a “buy” rating in a research report on Tuesday, August 15th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of CHF 262.69.
Shares of Roche Holding (VTX:ROG) opened at CHF 229 on Thursday. Roche Holding has a 1-year low of CHF 218.30 and a 1-year high of CHF 273.
TRADEMARK VIOLATION WARNING: This piece was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/11/16/roche-holding-ltd-rog-given-a-chf-290-price-target-by-jefferies-group-llc-analysts.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.